Terumo Corporation (FRA:TUO)

Market Cap	17.81B -28.6%
Revenue (ttm)	6.17B +9.2%
Net Income	741.35M +16.2%
EPS	0.50 +16.6%
Shares Out	n/a
PE Ratio	24.03
Forward PE	n/a
Dividend	0.17 (1.40%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	12.11
Previous Close	11.91
Day's Range	12.11 - 12.11
52-Week Range	10.15 - 16.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TUO

Financial Performance

In fiscal year 2026, Terumo's revenue was 1.13 trillion, an increase of 9.24% compared to the previous year's 1.04 trillion. Earnings were 135.91 billion, an increase of 16.19%.

Financial numbers in JPY